buspirone has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krupina, NA | 1 |
| Kryzhanovskiĭ, GN | 1 |
| Orlova, IN | 1 |
| Iordanskaia, TE | 1 |
1 other study available for buspirone and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
[Effects of buspirone on the development of an experimental depressive syndrome in rats, caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Buspirone; Depressive Disorder; Dopamine Agents; Mal | 1996 |